An overview of prognostic factors for long-term survivors of breast cancer
暂无分享,去创建一个
[1] A. Wolk,et al. Body weight and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status among Swedish women: A prospective cohort study , 2006, International journal of cancer.
[2] H. Verkooijen,et al. Social class is an important and independent prognostic factor of breast cancer mortality , 2006, International journal of cancer.
[3] T. Whelan,et al. Influence of hospital characteristics on operative death and survival of patients after major cancer surgery in Ontario. , 2006, Canadian journal of surgery. Journal canadien de chirurgie.
[4] M. García-Closas,et al. Established breast cancer risk factors by clinically important tumour characteristics , 2006, British Journal of Cancer.
[5] S. Shak,et al. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients , 2006, Breast Cancer Research.
[6] C. Hogue,et al. Multiple primary tumours in women following breast cancer, 1973–2000 , 2006, British Journal of Cancer.
[7] Irene L Andrulis,et al. HER2 and responsiveness of breast cancer to adjuvant chemotherapy. , 2006, The New England journal of medicine.
[8] C. Geyer,et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] P. V. van Diest,et al. Long‐term survival of T1 and T2 lymph node‐negative breast cancer patients according to mitotic activity index: A population‐based study , 2006, International journal of cancer.
[10] D. Slamon,et al. Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] H Brenner,et al. Higher long-term cancer survival rates in southeastern Netherlands using up-to-date period analysis. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] J. Prichard,et al. Breast cancer in elderly women: outcome as affected by age, tumor features, comorbidities, and treatment approach. , 2006, Clinical breast cancer.
[13] G. Colditz,et al. Meta-analysis of survival in African American and white American patients with breast cancer: ethnicity compared with socioeconomic status. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] J. Klijn,et al. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study. , 2006, International journal of radiation oncology, biology, physics.
[15] R W Blamey,et al. Prognostic value of lymphovascular invasion in women with lymph node negative invasive breast carcinoma. , 2006, European journal of cancer.
[16] R. Collins,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[17] A. Leclerc,et al. Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996 , 2005, British Journal of Cancer.
[18] D. Wickerham,et al. Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer , 2006, Breast Cancer Research and Treatment.
[19] T. Byers,et al. A Weight Loss Trial for Breast Cancer Recurrence: Pre-Menopausal, Post-Menopausal, Both, or Neither? , 2006, Cancer Causes & Control.
[20] F. Hu,et al. Dietary patterns and survival after breast cancer diagnosis. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] Graham A Colditz,et al. Alcohol and postmenopausal breast cancer risk defined by estrogen and progesterone receptor status: a prospective cohort study. , 2005, Journal of the National Cancer Institute.
[22] M. J. van de Vijver,et al. Long-term prognosis of patients with local recurrence after conservative surgery and radiotherapy for early breast cancer. , 2005, European journal of cancer.
[23] Y. Maehara,et al. The time-related changes of the importance of prognostic factors in breast cancer. A sequential multivariate analysis of 1423 Japanese patients , 2005, Breast Cancer Research and Treatment.
[24] E. Yu,et al. Short- and long-term cause-specific survival of patients with inflammatory breast cancer , 2005, BMC Cancer.
[25] Greg Yothers,et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. , 2005, The New England journal of medicine.
[26] D. Nerenz,et al. Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.
[27] R. Gelber,et al. Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005. , 2005, Annals of oncology : official journal of the European Society for Medical Oncology.
[28] Yu Shen,et al. Role of detection method in predicting breast cancer survival: analysis of randomized screening trials. , 2005, Journal of the National Cancer Institute.
[29] Y Wang,et al. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials , 2005, The Lancet.
[30] P. Bonnier,et al. Comparison of the prognosis indication of VEGFR-1 and VEGFR-2 and Tie2 receptor expression in breast carcinoma. , 2005, International journal of oncology.
[31] J. Coebergh,et al. Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based study. , 2005, European journal of cancer.
[32] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[33] S. Tretli,et al. Weak associations between sociodemographic factors and breast cancer: possible effects of early detection , 2005, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[34] Darrell N. Smith,et al. Prognosis after local recurrence after conservative surgery and radiation for early-stage breast cancer. , 2005, International journal of radiation oncology, biology, physics.
[35] G. Colditz. Estrogen, estrogen plus progestin therapy, and risk of breast cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[36] Graham A Colditz,et al. Physical activity and survival after breast cancer diagnosis. , 2004, JAMA.
[37] B. Haffty,et al. Clinicopathologic features and long-term outcome of patients with medullary breast carcinoma managed with breast-conserving therapy (BCT). , 2003, International journal of radiation oncology, biology, physics.
[38] A. Patchefsky,et al. Interobserver reproducibility of histopathological features in stage II breast cancer , 1985, Breast Cancer Research and Treatment.
[39] K. Zedeler,et al. Correlation of growth fraction by Ki-67 and proliferating cell nuclear antigen (PCNA) immunohistochemistry with histopathological parameters and prognosis in primary breast carcinomas , 2005, Breast Cancer Research and Treatment.
[40] I. Ellis,et al. The Nottingham prognostic index in primary breast cancer , 2005, Breast Cancer Research and Treatment.
[41] N. Wolmark,et al. Treatment of axillary lymph node-negative, estrogen receptor-negative breast cancer: updated findings from National Surgical Adjuvant Breast and Bowel Project clinical trials. , 2004, Journal of the National Cancer Institute.
[42] J. Bryant,et al. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials , 2004, The Lancet.
[43] V. Kataja,et al. Risk for distant recurrence of breast cancer detected by mammography screening or other methods. , 2004, JAMA.
[44] Michael Gnant,et al. Prognostic Value of Lymphangiogenesis and Lymphovascular Invasion in Invasive Breast Cancer , 2004, Annals of surgery.
[45] F. Akiyama,et al. Improvement in the prognosis of Japanese breast cancer patients from 1946 to 2001--an institutional review. , 2004, Japanese journal of clinical oncology.
[46] A. Goldhirsch,et al. Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experience. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[47] J. Coebergh,et al. Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patients , 2004, British Journal of Cancer.
[48] S. Chia,et al. Ten-year outcomes in a population-based cohort of node-negative, lymphatic, and vascular invasion-negative early breast cancers without adjuvant systemic therapies. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[49] J. Coebergh,et al. Using loco-regional recurrence as an indicator of the quality of breast cancer treatment. , 2004, European journal of cancer.
[50] Hermann Brenner,et al. Are patients diagnosed with breast cancer before age 50 years ever cured? , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] H Brenner,et al. Period analysis for 'up-to-date' cancer survival data: theory, empirical evaluation, computational realisation and applications. , 2004, European journal of cancer.
[52] P. Bonnier,et al. Long-term prognostic significance of neoangiogenesis in breast carcinomas: comparison of Tie-2/Tek, CD105, and CD31 immunocytochemical expression. , 2004, Human pathology.
[53] T. Nishikawa,et al. Blood Vessel Invasion as a Predictor of Long-Term Survival for Japanese Patients with Breast Cancer , 2002, Breast Cancer Research and Treatment.
[54] T. Nishikawa,et al. Angiogenesis as a predictor of long-term survival for 377 Japanese patients with breast cancer , 2001, Breast Cancer Research and Treatment.
[55] F Berrino,et al. EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[56] J. Satagopan,et al. A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment , 2003, Breast Cancer Research.
[57] E. Mamounas,et al. Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. , 2003, Journal of the National Cancer Institute.
[58] Tim Byers,et al. Nutrition and Physical Activity During and After Cancer Treatment: An American Cancer Society Guide for Informed Choices , 2003, CA: a cancer journal for clinicians.
[59] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[60] F. Bray,et al. Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.
[61] D. Forman,et al. Surgeon workload and survival from breast cancer , 2003, British Journal of Cancer.
[62] Larry Norton,et al. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[63] J. Hendriks,et al. Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review , 2003, The Lancet.
[64] L. Tabár,et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.
[65] J. Ragaz,et al. Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[66] Richard J. K. Taylor,et al. Long-term survival of women with breast cancer in New South Wales. , 2003, European journal of cancer.
[67] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[68] L. Belghiti,et al. Prognostic factors in breast cancer , 2002 .
[69] C. Hill,et al. Prediction of the long‐term survival in breast cancer patients according to the present oncological status , 2002, Statistics in medicine.
[70] S. Costa,et al. Factors influencing the prognostic role of oestrogen and progesterone receptor levels in breast cancer--results of the analysis of 670 patients with 11 years of follow-up. , 2002, European journal of cancer.
[71] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[72] T. Nishikawa,et al. p53, mitosis, apoptosis and necrosis as prognostic indicators of long-term survival in breast cancer. , 2002, Anticancer research.
[73] M. Campiglio,et al. HER-2-positive breast carcinomas as a particular subset with peculiar clinical behaviors. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[74] M Bracko,et al. Long term prognostic value of Nottingham histological grade and its components in early (pT1N0M0) breast carcinoma. , 2002, Journal of clinical pathology.
[75] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[76] S. Singletary,et al. Prognostic Factors in Node-Negative Breast Cancer: A Review of Studies With Sample Size More Than 200 and Follow-Up More Than 5 Years , 2002, Annals of surgery.
[77] I. Ellis,et al. Prognostic significance of synchronous and metachronous bilateral breast cancer , 2001, World Journal of Surgery.
[78] P. Kyyrönen,et al. Survival of breast cancer patients in BRCA1, BRCA2, and non‐BRCA1/2 breast cancer families: A relative survival analysis from Finland , 2001, International journal of cancer.
[79] A. Vincent-Salomon,et al. Long term outcome of small size invasive breast carcinomas independent from angiogenesis in a series of 685 cases , 2001, Cancer.
[80] A. Thor,et al. Measures of cell turnover (proliferation and apoptosis) and their association with survival in breast cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[81] D. Hole,et al. Prognostic factors in women with breast cancer: distribution by socioeconomic status and effect on differences in survival , 2001, Journal of epidemiology and community health.
[82] B Fisher,et al. Fifteen‐year prognostic discriminants for invasive breast carcinoma , 2001, Cancer.
[83] C. Giardina,et al. Prognostic factors in breast cancer: the predictive value of the Nottingham Prognostic Index in patients with a long-term follow-up that were treated in a single institution. , 2001, European journal of cancer.
[84] G. Vorgias,et al. Prognostic significance of factors affecting disease free interval and overall survival for Stage II breast cancer in Greece. A multivariate cohort study. , 2001, European journal of obstetrics, gynecology, and reproductive biology.
[85] S. Martino,et al. Prediction of Node-Negative Breast Cancer Outcome by Histologic Grading and S-Phase Analysis by Flow Cytometry: An Eastern Cooperative Oncology Group Study (2192) , 2001, American journal of clinical oncology.
[86] R. Gelber,et al. Tubular carcinoma of the breast: Prognosis and response to adjuvant systemic therapy , 2001, ANZ journal of surgery.
[87] F. Spyratos,et al. Relationship between c-erbB-2 and other tumor characteristics in breast cancer prognosis. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[88] S. Edge,et al. Prognostic factors in breast cancer , 2005 .
[89] D. Fischer,et al. Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[90] R. Gelber,et al. Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? , 2000, The Lancet.
[91] Mike Clarke,et al. UK and USA breast cancer deaths down 25% in year 2000 at ages 20–69 years , 2000, The Lancet.
[92] A. Ramaioli,et al. P53 determination alongside classical prognostic factors in node-negative breast cancer: an evaluation at more than 10-year follow-up. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[93] R. Riffenburgh,et al. Survival of patients with untreated breast cancer , 2000, Journal of surgical oncology.
[94] P. Andersen,et al. Factors influencing the effect of age on prognosis in breast cancer: population based study , 2000, BMJ : British Medical Journal.
[95] J. Nesland,et al. The prognostic value of p53 and c‐erb b‐2 immunostaining is overrated for patients with lymph node negative breast carcinoma , 2000, Cancer.
[96] P. Houts,et al. ACS cancer facts and figures , 2000 .
[97] W. Willett,et al. Dietary factors and the survival of women with breast carcinoma , 1999, Cancer.
[98] R. Coombes,et al. Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study , 1999, The Lancet.
[99] W. Hepburn,et al. 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening , 1999, The Lancet.
[100] I. Ellis,et al. The prognosis of small primary breast cancers. , 1999, European journal of cancer.
[101] S. Tsutsui,et al. Prognostic impact of second cancer on the survival of early breast cancer patients. , 1999, International journal of oncology.
[102] A. Jemal,et al. Global cancer statistics , 2011, CA: a cancer journal for clinicians.
[103] S. Pinder,et al. The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy , 1998, Cancer.
[104] K Vajda,et al. [Prognostic factors in breast cancer]. , 1998, Orvosi hetilap.
[105] C. Lewis,et al. Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[106] B. Wójcik,et al. Breast carcinoma survival analysis for african american and white women in an equal‐access health care system , 1998, Cancer.
[107] S. Tretli,et al. Long-term survival of breast cancer in Norway by age and clinical stage. , 1997, Statistics in medicine.
[108] I. Ellis,et al. Early-onset breast cancer--histopathological and prognostic considerations. , 1997, British Journal of Cancer.
[109] D. Wartenberg,et al. The importance of histologic type on breast cancer survival. , 1997, Journal of clinical epidemiology.
[110] R. Hiatt,et al. Comorbidity and breast cancer survival: a comparison between black and white women. , 1996, Annals of epidemiology.
[111] E. Feuer,et al. The impact of stage and histology on the long‐term clinical course of 163,808 patients with breast carcinoma , 1996, Cancer.
[112] V. Kosma,et al. Expression of p53 protein has no independent prognostic value in breast cancer , 1995, The Journal of pathology.
[113] G. Jacobsen,et al. An immunohistochemical study of p53 with correlations to histopathological parameters, c-erbB-2, proliferating cell nuclear antigen, and prognosis. , 1995, Human pathology.
[114] K. Zedeler,et al. Proliferating cell nuclear antigen (pcna) and C-erbb-2 oncoprotein in breast-carcinoma with correlations to histopathological parameters and prognosis. , 1995, Oncology reports.
[115] Steven E. Bayer,et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. , 1994, Science.
[116] F. Rosato,et al. Diseases of the Breast , 1972 .
[117] E T BELL,et al. The Diseases of the Breast , 1925, Nature.